Koyfin Home > Directory > Health Care > Boston Scientific Corp > Total Debt / Equity

Boston Scientific Corp Total Debt / Equity Chart (BSX)

Boston Scientific Corp annual/quarterly Total Debt / Equity from 2010 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Boston Scientific Corp Total Debt / Equity for the quarter ending September 09, 2020 was $62m a -21.03% decrease of -13m year over year
  • Boston Scientific Corp Total Debt / Equity for the last 12 months ending September 09, 2020 was $62m a -21.03% decrease of -13m year over year
  • Boston Scientific Corp Annual Total Debt / Equity for 2019 was $75m a -9.08% decrease of -7m from 2018
  • Boston Scientific Corp Annual Total Debt / Equity for 2018 was $81m a 1.57% increase of 1m from 2017
  • Boston Scientific Corp Annual Total Debt / Equity for 2017 was $80m a -1.70% decrease of -1m from 2016
Other Ratios Metrics:
  • Boston Scientific Corp Total Debt / Capital for the quarter ending December 12, 2018 was $44m a -1.42% decrease of -1m year over year
  • Boston Scientific Corp Other Liabilities for the quarter ending September 09, 2018 was $2,202m a -16.30% decrease of -359m year over year
View Chart On Koyfin

Quarterly BSX Total Debt / Equity Data

09/2020$62m
06/2020$63m
03/2020$77m
12/2019$75m
09/2019$115m
06/2019$104m
03/2019$103m
12/2018$81m
09/2018$80m
06/2018$84m

Annual BSX Total Debt / Equity Data

2019$75m
2018$81m
2017$80m
2016$81m
2015$90m
2014$66m
2013$65m
2012$62m
2011$38m
2010$48m